BioNexus Gene Lab Corp (BGLC)
0.55
-0.02
(-3.59%)
USD |
NASDAQ |
May 21, 16:00
0.55
0.00 (0.00%)
After-Hours: 16:37
BioNexus Gene Lab Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
Balchem Corp | 0.2795 |
Friedman Industries Inc | 0.3745 |
Solitario Resources Corp | -- |
Golden Minerals Co | -- |
Paramount Gold Nevada Corp | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 11.16M |
Total Liabilities (Quarterly) | 1.817M |
Shareholders Equity (Quarterly) | 9.344M |
Current Ratio | 4.606 |